These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21083544)

  • 21. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
    Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
    Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
    Breneman D; Fleischer AB; Abramovits W; Zeichner J; Gold MH; Kirsner RS; Shull TF; Crowe AW; Jaracz E; Hanifin JM;
    J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment.
    Doss N; Kamoun MR; Dubertret L; Cambazard F; Remitz A; Lahfa M; de Prost Y
    Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):321-9. PubMed ID: 19563466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of fluticasone propionate 0.005% ointment in the long-term maintenance treatment of children with atopic dermatitis: differences between boys and girls?
    Glazenburg EJ; Wolkerstorfer A; Gerretsen AL; Mulder PG; Oranje AP
    Pediatr Allergy Immunol; 2009 Feb; 20(1):59-66. PubMed ID: 18298423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
    Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus ointment for the treatment of atopic dermatitis.
    Boucher M
    Issues Emerg Health Technol; 2001 Jul; (19):1-4. PubMed ID: 11776288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis.
    Drake L; Prendergast M; Maher R; Breneman D; Korman N; Satoi Y; Beusterien KM; Lawrence I
    J Am Acad Dermatol; 2001 Jan; 44(1 Suppl):S65-72. PubMed ID: 11145797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of topically applied tacrolimus ointment in patients with moderate to severe atopic dermatitis.
    Wong WR; Tsai HJ; Hong HS
    Chang Gung Med J; 2003 Jul; 26(7):485-95. PubMed ID: 14515971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.
    Reitamo S; Van Leent EJ; Ho V; Harper J; Ruzicka T; Kalimo K; Cambazard F; Rustin M; Taïeb A; Gratton D; Sauder D; Sharpe G; Smith C; Jünger M; de Prost Y;
    J Allergy Clin Immunol; 2002 Mar; 109(3):539-46. PubMed ID: 11898004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
    Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
    N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
    Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
    Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis.
    Taneja C; Antaya RJ; Berger A; Marshall TS; Seifeldin R; Oster G
    J Drugs Dermatol; 2010 Apr; 9(4):372-6. PubMed ID: 20514795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial.
    Mandelin J; Remitz A; Virtanen H; Reitamo S
    Acta Derm Venereol; 2010 Mar; 90(2):170-4. PubMed ID: 20169301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
    Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
    J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pimecrolimus cream and Tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference.
    Onumah N; Kircik L
    J Drugs Dermatol; 2013 Oct; 12(10):1145-8. PubMed ID: 24085050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis.
    McCollum AD; Paik A; Eichenfield LF
    Pediatr Dermatol; 2010; 27(5):425-36. PubMed ID: 20678096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
    Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N
    Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of once-daily vs twice-daily tacrolimus among Hispanic and Black kidney transplant recipients.
    Hurwitz JT; Grizzle AJ; Tyler CS; Zapata LV; Malone DC
    J Manag Care Spec Pharm; 2021 Jul; 27(7):948-960. PubMed ID: 34185556
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
    Lazzaro C; McKechnie T; McKenna M
    J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment.
    Kawashima M;
    Int J Dermatol; 2006 Jun; 45(6):731-6. PubMed ID: 16796638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.